Results 21 to 30 of about 37,412,989 (241)
An introduction to physiologically‐based pharmacokinetic models
SummaryPhysiologically‐based pharmacokinetic (PBPK) models represent drug kinetics in one or more ‘real’ organs (and hence require submodels of organs/tissues) and they describe ‘whole‐body’ kinetics by joining together submodels with drug transport by blood flow as dictated by anatomy.
Richard N. Upton +2 more
openaire +3 more sources
Pregnancy is associated with physiological changes that may affect drug pharmacokinetics (PKs). The aim of this study was to establish a maternal–fetal physiologically based pharmacokinetic (PBPK) model of oxcarbazepine (OXC) and its active metabolite ...
Lixia He +7 more
doaj +1 more source
Unraveling bisphenol A pharmacokinetics using physiologically based pharmacokinetic modeling [PDF]
Physiologically based pharmacokinetic (PBPK) models integrate both chemical- and system-specific information into a mathematical framework, offering a mechanistic approach to predict the internal dose metrics of a chemical and an ability to perform species and dose extrapolations.
Yang, Xiaoxia, Fisher, Jeffrey W.
openaire +3 more sources
Applications of physiologically based pharmacokinetic modeling for the optimization of anti-infective therapies [PDF]
Introduction: The pharmacokinetic properties of anti-infective drugs are a determinant part of treatment success. Pathogen replication is inhibited if adequate drug levels are achieved in target sites, whereas excessive drug concentrations linked to ...
core +1 more source
Background: Voriconazole is a potent antifungal drug with complex pharmacokinetics caused by time-dependent inhibition and polymorphisms of metabolizing enzymes. It also exhibits different pharmacokinetic characteristics between adults and children.
Yahui Zhang +7 more
doaj +1 more source
A minimal physiologically based pharmacokinetic model for high-dose methotrexate [PDF]
Purpose: High-dose methotrexate (HDMTX) is administered for the treatment of a variety of malignant tumors. Wide intra- and inter-individual variabilities characterize the pharmacokinetics of MTX, which is mostly excreted renally.
Foppoli M., Manca D., Pesenti G.
core +2 more sources
Physiologically Based Pharmacokinetic Modeling of Therapeutic Proteins [PDF]
Biologics or therapeutic proteins are becoming increasingly important as treatments for disease. The most common class of biologics are monoclonal antibodies (mAbs). Recently, there has been an increase in the use of physiologically based pharmacokinetic (PBPK) modeling in the pharmaceutical industry in drug development.
Harvey, Wong, Timothy W, Chow
openaire +2 more sources
A Physiologically Based Pharmacokinetic Model of Rifampin in Mice [PDF]
ABSTRACT One problem associated with regimen-based development of antituberculosis (anti-TB) drugs is the difficulty of a systematic and thorough in vivo evaluation of the large number of possible regimens that arise from consideration of multiple drugs tested together.
Michael A, Lyons +3 more
openaire +2 more sources
Minimal physiologically‐based pharmacokinetic (mPBPK) models are frequently used to model plasma pharmacokinetic (PK) data and utilize and yield physiologically relevant parameters. Compared with classical compartment and whole‐body physiologically‐based
Panteleimon D. Mavroudis +2 more
doaj +1 more source
Pediatric physiologically‐based pharmacokinetic (PBPK) models have broad application in the drug development process and are being used not only to project doses for clinical trials but increasingly to replace clinical studies.
Trevor N. Johnson +3 more
doaj +1 more source

